186 related articles for article (PubMed ID: 2473951)
1. Application of keratin immunocytochemistry and sirius red staining in evaluating intrahepatic changes with acute extrahepatic cholestasis due to hepatic duct carcinoma.
James J; Lygidakis NJ; van Eyken P; Tanka AK; Bosch KS; Ramaekers FC; Desmer V
Hepatogastroenterology; 1989 Jun; 36(3):151-5. PubMed ID: 2473951
[TBL] [Abstract][Full Text] [Related]
2. [Hepatic neoductules].
Fischer HP; Meybehm M; Zhou H; Schoch J
Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
[TBL] [Abstract][Full Text] [Related]
3. Histopathology of cholestasis.
Desmet VJ
Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
Elmore LW; Sirica AE
Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
[TBL] [Abstract][Full Text] [Related]
5. Early changes in cholestatic livers as a consequence of hepatic duct carcinoma: a histological and histochemical exploration.
James J; Frederiks WM; Van Noorden CJ
Semin Liver Dis; 1990 May; 10(2):91-101. PubMed ID: 2162570
[No Abstract] [Full Text] [Related]
6. The development of proliferating ductular structures in liver disease. An immunohistochemical study.
Thung SN
Arch Pathol Lab Med; 1990 Apr; 114(4):407-11. PubMed ID: 1690977
[TBL] [Abstract][Full Text] [Related]
7. Morphologic changes of extrahepatic bile ducts during obstruction and subsequent decompression by endoprosthesis.
Karsten TM; Coene PP; van Gulik TM; Bosma A; van Marle J; James J; Lygidakis NJ; Klopper PJ; van der Heyde MN
Surgery; 1992 May; 111(5):562-8. PubMed ID: 1598676
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing carcinoma of the right hepatic duct at the porta hepatis: anicteric presentation of early hilar cholangiocarcinoma.
Axiotis CA; Smith GJ
Am J Gastroenterol; 1982 Jun; 77(6):414-8. PubMed ID: 6283880
[TBL] [Abstract][Full Text] [Related]
9. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
11. Identification of bipotential progenitor cells in human liver regeneration.
Haque S; Haruna Y; Saito K; Nalesnik MA; Atillasoy E; Thung SN; Gerber MA
Lab Invest; 1996 Nov; 75(5):699-705. PubMed ID: 8941215
[TBL] [Abstract][Full Text] [Related]
12. [Histological changes in liver tissue in cholestasis].
Machnik G
Z Gastroenterol; 1993 Feb; 31 Suppl 2():7-10. PubMed ID: 7483720
[TBL] [Abstract][Full Text] [Related]
13. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
15. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Van de Casteele M; Roskams T; Van der Elst I; van Pelt JF; Fevery J; Nevens F
Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
[TBL] [Abstract][Full Text] [Related]
16. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholestasis without jaundice.
Namdar T; Raffel A; Topp SA; am Esch JS; Fürst G; Knoefel WT; Eisenberger CF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):103-5. PubMed ID: 19208525
[TBL] [Abstract][Full Text] [Related]
18. Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.
Chen Y; Guldiken N; Spurny M; Mohammed HH; Haybaeck J; Pollheimer MJ; Fickert P; Gassler N; Jeon MK; Trautwein C; Strnad P
J Pathol; 2015 Nov; 237(3):343-54. PubMed ID: 26108453
[TBL] [Abstract][Full Text] [Related]
19. Modified Longmire's operation for proximal extrahepatic biliary obstruction.
Goh HS; Rauff A; Foong WC; Tan L
Singapore Med J; 1984 Apr; 25(2):92-6. PubMed ID: 6089354
[No Abstract] [Full Text] [Related]
20. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
